Marek Liyanage
- Molecular Biology top 2%
- DNA Repair Mechanisms 6
- Melanoma and MAPK Pathways 3
- PI3K/AKT/mTOR signaling in cancer 2
- Wnt/β-catenin signaling in development and cancer 2
- Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment 3
- Oncology top 5%
- Cancer-related Molecular Pathways 8
- Aging top 5%
- Cell Biology top 2%
-
- Genomic variations and chromosomal abnormalities 5
-
- Chromosomal and Genetic Variations 2
- Co-authors
- Thomas RiedCarrolee BarlowAnthony Wynshaw‐BorisDanilo A. TagleMichael EckhausShinji HirotsuneFrancis S. CollinsJacqueline N. Crawley
- Journals
- Bioorganic & Medicinal Chemistry Letters (3 papers)Genes Chromosomes and Cancer (2 papers)Nature Genetics (2 papers)
- Partner nations
- United StatesIsraelSweden
In The Last Decade
Marek Liyanage
22 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Molecular Biology 2.6k
- Cancer Research 560
- Oncology 862
- Aging 51
- Cell Biology 463
Countries citing papers authored by Marek Liyanage
This map shows the geographic impact of Marek Liyanage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Liyanage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Liyanage more than expected).
Fields of papers citing papers by Marek Liyanage
This network shows the impact of papers produced by Marek Liyanage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Liyanage. The network helps show where Marek Liyanage may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marek Liyanage, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 20 | |
| 2 | 2011 | 7 | |
| 3 | 2011 | 20 | |
| 4 | 2006 | 341 | |
| 5 | 2000 | 20 | |
| 6 | 2000 | 10 | |
| 7 | 2000 | 127 | |
| 8 | 1999 | 67 | |
| 9 | 1999 | 3 | |
| 10 | 1998 | 37 | |
| 11 | 1998 | 70 | |
| 12 | 1998 | 214 | |
| 13 | 1997 | 74 | |
| 14 | 1997 | 99 | |
| 15 | 1997 | 2 | |
| 16 | 1996 | 243 | |
| 17 | Atm-Deficient Mice: A Paradigm of Ataxia Telangiectasiabreakdown → | 1996 | 1211 |
| 18 | 1995 | 75 | |
| 19 | Evidence for different signalling pathways of PKC zeta and ras-p21 in Xenopus oocytes. | 1995 | 18 |
| 20 | Activation of the c-Raf protein kinase by protein kinase C phosphorylation. | 1992 | 267 |
About Marek Liyanage
Marek Liyanage is a scholar working on Oncology, Cancer Research and Physiology, having authored 22 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (8 papers), DNA Repair Mechanisms (6 papers), Genomic variations and chromosomal abnormalities (5 papers), Carcinogens and Genotoxicity Assessment (3 papers), Melanoma and MAPK Pathways (3 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Chromosomal and Genetic Variations (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). The work is most often cited by research in Molecular Biology (2.6k citations), Cancer Research (560 citations) and Oncology (862 citations). Marek Liyanage has collaborated with scholars based in United States, Israel and Sweden. Frequent co-authors include Thomas Ried, Carrolee Barlow, Anthony Wynshaw‐Boris, Danilo A. Tagle, Michael Eckhaus, Shinji Hirotsune, Francis S. Collins, Jacqueline N. Crawley, Richard Paylor and Yosef Shiloh. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Genes Chromosomes and Cancer, Nature Genetics, Oncogene and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.